Citurgia Biochemicals Profile
Key Indicators
- Authorised Capital ₹ 27.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 26.42 Cr
as on 12-12-2024
- Company Age 50 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 26.46 Cr
as on 12-12-2024
- Satisfied Charges ₹ 34.52 Cr
as on 12-12-2024
- Revenue %
(FY 2022)
- Profit 33.96%
(FY 2022)
- Ebitda 52.14%
(FY 2022)
- Net Worth -7.69%
(FY 2022)
- Total Assets -2.19%
(FY 2022)
About Citurgia Biochemicals
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 506373.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 27.00 Cr and a paid-up capital of Rs 26.42 Cr.
The company currently has active open charges totaling ₹26.46 Cr. The company has closed loans amounting to ₹34.52 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kashi Nath, Vivek Singh, Dharmendra, and Three other members serve as directors at the Company.
- CIN/LLPIN
L24100MH1974PLC017773
- Company No.
017773
- Stock Symbol
BSE : 506373
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Sep 1974
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Citurgia Biochemicals?
Board Members(6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kashi Nath | Whole-Time Director | 11-Mar-2022 | Current |
Vivek Singh | Director | 17-Apr-2010 | Current |
Dharmendra | Director | 27-Jan-2021 | Current |
Jitendra | Director | 31-Aug-2022 | Current |
Subhash Sahu | Director | 31-Aug-2022 | Current |
Reena Mandal | Director | 31-Mar-2018 | Current |
Financial Performance and Corporate Structure Insights of Citurgia Biochemicals.
Citurgia Biochemicals Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 33.96% increase in profit. The company's net worth dipped by a decrease of 7.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Citurgia Biochemicals?
In 2022, Citurgia Biochemicals had a promoter holding of 99.67% and a public holding of 0.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Green Leafe Infrastructure LimitedActive 18 years 1 month
Jitendra and Subhash Sahu are mutual person
- Satya Sheel Engineers And Miners Private LimitedActive 35 years 6 months
Kashi Nath and Subhash Sahu are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Union Bank Of India Creation Date: 15 Mar 2001 | ₹2.10 Cr | Open |
Industrial Investment Bank Of India Ltd Creation Date: 14 May 1998 | ₹10.00 Cr | Open |
Oriental Bank Of Commerce Creation Date: 17 Aug 1994 | ₹2.20 Cr | Open |
How Many Employees Work at Citurgia Biochemicals?
Unlock and access historical data on people associated with Citurgia Biochemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Citurgia Biochemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Citurgia Biochemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.